Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NSRX compared with XAIR: revenue, margins and what each company keeps, and the suppliers and customers both name
NSRX
Nasus Pharma Ltd
Change
Mkt cap
Revenue
Revenue
XAIR
Beyond Air, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NSRX
Nasus Pharma Ltd
vs
XAIR
Beyond Air, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
NSRX
No earnings history for NSRX.
XAIR
2 of 4 reports
Report
implied
realized
× implied
Oct 8 '26
—
▼
−9.06%
—
Q1 FY27
—
▼
−9.08%
—
= implied
NSRX realized, solid
XAIR realized, hatched
One scale, both sides: full bar = 10%
× = |realized| ÷ implied
Source: market data
NSRX
Nasus Pharma Ltd
Change
3.20
▲
+0.31%
· post 3.20
Mkt cap
$24.6M
Revenue
—
Revenue
—
XAIR
Beyond Air, Inc.
Change
2.36
▲
+2.16%
· post 2.36
Closed
Oct 30 '26
Mkt cap
$2.1M
Revenue
$2M
Q1 FY27
Revenue
$8M
FY26
vs
Compare
Closed
Oct 30 '26
NSRX
Nasus Pharma Ltd
vs
XAIR
Beyond Air, Inc.
3.20
▲
+0.31%
post 3.20
Price
2.36
▲
+2.16%
post 2.36
$24.6M
Mkt cap
$2.1M
—
Revenue
$2M
Q1 FY27
—
Revenue
$8M
FY26
Change
Change
NSRX
3.20
▲
+0.31%
vs
XAIR
2.36
▲
+2.16%
Closed
Oct 30 '26